Anti-promotion effect of chlorophyllin in DMBA-TPA-Induced mouse skin carcinogenesis

Anticancer Research

Volumn 20, Issue 3 A, 2000, Pages 1493-1498

  Kim, Jin ^a,b   Yook, Jong In ^a   Park, Kwang Kyun ^a   Jung, So Young ^a   Hong, Joon Chul ^a   Kim, Kyung Ju ^a   Kim, Jin A ^a   Chung, Won Yoon ^a  

^a Yonsei University College of Dentistry   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

C jun family; Chemoprevention; Chlorophyllin; Ornithine decarboxylase; Proliferating activity; Promotion stage

Indexed keywords

CHLOROPHYLL; DIMETHYLBENZ[A]ANTHRACENE; MESSENGER RNA; ORNITHINE DECARBOXYLASE; PROTEIN C JUN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CARCINOGENESIS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTIMUTAGENIC AGENTS; CARCINOGENS; CELL DIVISION; CHLOROPHYLLIDES; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED ICR; ORNITHINE DECARBOXYLASE; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 0033854437     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Sporn MB: Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 36: 2699-2702, 1976.
2. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, Fofonoff S, Byers R, Atkinson EN, Vaughan C, Toth BB, Kramer A, Dimery IW, Skipper P and Strong S: 13-cis-retinoic acid in the treatment of oral leukoplakia. N. Engl J Med 315: 1501-1505, 1986.
3. Lippman S, Batsakis JG, Toth BB, Weber RS, Lee JJ, Martin JW, Hays GL, Goepfert H and Hong WK: Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 328: 15-20, 1993.
4. Wattenberg LW: Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 52: 2085s-2091s, 1992.
5. Burke JF and Golden T: A clinical evaluation of enzymatic debridement with Papain-Urea-Chlorophyllin ointment. Am J Surg 95: 828-842, 1958.
6. Lam CR and Brush B: Chlorophyll and wound healing. Am J Surg 80: 204-210, 1950.
7. Nahata MC, Slencsak CA and Kamp J: Effect of chlorophyllin on urinary odor in incontinent geriatric patients. Drg Intell Clin Pharm 17: 732-734, 1983.
8. Dashwood RH: Chlorophylls as anticarcinogens (Review). In J Oncol 10: 721-27, 1997.
9. Dashwood RH, Breinholt V and Bailey GS: Chemopreventive propertis of chlorophyllin: inhibition of aflatoxin B1 (AFB1)-DNA binding in vivo and antimutagenic activity against AFB1 and two heterocyclic amines in the Salmonella mutagenicity assay. Carcinogenesis 12: 939-942, 1991.
10. Warner JR, Joginder N and Ong T: Antimutagenecity studies of chlorophyllin using the Samonella arabinose resistant assay system. Mutat Res 262: 25-30, 1991.
11. Katoh Y, Nemoto N and Tanaka M: Inhibition of benzo(a)pyrene mutagenesis in Chinese hamster V79 cells by hemin and related compounds. Mutat Res 121: 153-157, 1983.
12. Surh YJ, Park KK and Shlyankevich M: Inhibitory effects of chlorophyllin on chmeically induced mutagenesis and carcinogenesis. Ann New York Acad Sci 768: 246-9, 1995.
13. Park KK, Surh YJ and Miller JA: Chemopreventive properties of chlorophyllin against vinyl carbamate, p-nitrophenyl vinyl ether and their electrophilic epoxides. Cancer Lett 94: 33-40, 1995.
14. Breinholt V, Schimerlik M, Dashwood R and Bailey G: Mechanisms of chlorophyllin anticarcinogenesis against Aflatoxin B1: complex formation with the carcinogen. Chem Res Toxicol 8: 506-514, 1995.
15. Dashwood RH: Protection by chlorophyllin against the covalent binding of 2-amino-3-methylimidazo(4,5-f)quinone(IQ) to rat liver DNA. Carcinogenesis 13: 113-118, 1992.
16. Dashwood RH and Guo D: Inhibition of 2-amino-3-methylimidazo (4,5-f)quinone(IQ)-DNA binding by chlorophyllin: studies of enzyme inhibition and molecular complex formation to rat liver DNA. Carcinogenesis 13: 1121-1126, 1992.
17. Imai K, Aimoto T, Sato M, Watanabe K, Kimura R and Murata T: Effects of sodium metallochlorophyllins on the activity and components of the microsomal drug-metabolizing enzyme system in rat liver. Chem Pharm Bull 34: 4287-4293, 1986.
18. Sato M, Imai K, Kimura R and Murata T: Effect of sodium copper chlorophyllin lipid peroxidation. IV. Effect of its administration on mitochondrial and microsomal lipid perixodiation in rat liver. Chem Pharm Bull 32: 716-22, 1984.
19. Pegg AE and McCann PP: Polyamine metabolism and function. Am J Physiol 243: 212-221, 1982.
20. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48: 759-774, 1988.
21. Halmekyto M, Syrjanen K, Janne J and Alhonen L: Enhanced papilloma formation in response to skin tumor promotion in transgenic mice overexpressing the human ornithine decarboxylase gene. Biochem Biophys Res Commun 187: 493-497, 1992.
22. Megosh L, Gilmour SK, Rosson D, Soler AP, Blessing M, Sawicki JA and OBrien TG: Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Res 55: 4205-4209, 1995.
23. Auvinen M, Passinen A, Andersson LC and Holtta E: Ornithine decarboxylase activity is critical for cell transformation. Nature 360: 355-358, 1992.
24. Clifford A, Morgan D, Yuspa SH, Soler AP and Gilmour S: Role of ornithine decarboxylase in epidermal tumorgenesis. Cancer Res 55: 1680-1686, 1995.
25. OBrien TG, Megosh LC, Gilliard G and Soler AP: Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res 57: 2630-2637, 1997.
26. Pegg AE, Shantz LM and Coleman CS: Ornithine decarboxylase as a target for chemoprevention. J Cell Biochem 22: 132s-138s, 1995.
27. Gerhauser C, Lee SK, Kosmeder JW, Moriarty RM, Hamel E, Mehta RG, Moon RC and Pezzuto JM: Regulation of ornithine decarboxylase induction by deguelin, a natural product cancer Chemopreventive agent. Cancer Res 57: 3429-3435, 1997.
28. Lee W, Mitchell P and Tjian R: Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49: 741-752, 1987.
29. Lamph WW, Wamsley P, Sassone-Corsi P and Verma IM: Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature 334: 629-631, 1988.
30. Nelson R: Chlorophyllin, an antimutagen, acts as a tumor promotor in the rat-dimethylhydrazine colon carcinogenesis model. Anticancer Res 12: 737-740, 1992.
31. Chung WY, Lee JM, Park MY, Yook JI, Kim J, Chung AS, Surh YJ and Park KK: Inhibitory effects of chlorophyllin on 7,12-dimethyl-benz[a]anthracene-induced bacterial mutagenesis and mouse skin carcinogenesis. Cancer Lett 145: 57-64, 1999.
32. Kim J and Shine DM: Biomarkers of squamous cell carcinoma of the head and neck. Histol Histopathol 12: 205-218, 1997.
33. Shin DM, Voravud N, Ro JY, Lee JS, Hong WK and Hittelman WN: Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: A potential biomarker. J Natl Cancer Inst 85: 971-978, 1993.
34. Cosenza SC, Owen TA, Soprano DR and Soprano KJ: Evidence that the time of entry into S is determined by events occurring in early G1. J Biol Chem 263: 12751-12758, 1988.
35. Angel P and Karin M: The role of Jun, fos and the AP-1 complex in cell-proliferation and transformation. Biochem Biophy Acta 1072: 129-157, 1992.
36. Sassone-Corsi P, Sisson JC and Verma IM: Transcriptional autoregulation of the proto-oncogene fos. Nature 334: 314-319, 1988.
37. Schonthal A, Buscher M, Angel P, Rahmsdorf HJ, Ponta H, Hattori K, Chiu R, Karin M and Herrlich P: The Fos and Jun/AP-1 proteins are involved in the downregulation of Fos transcription. Oncogene 4: 629-636, 1989.
38. Angel P, Hattori K, Smeal T and Karin M: The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55: 875-885, 1988.
39. Chiu R, Angel P and Karin M: Jun-B differs in its biological properties from, and is a negative regulator of c-Jun. Cell 59: 979-986, 1989.